Investor
News & Events
Financial Reports
Stock Information
Corporate Governance
Contacts & Alerts
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Danaher Corporation announced that President and Chief Executive Officer, H. Lawrence Culp, Jr. will be presenting at the Barclays Capital Industrial Select Conference in Miami, FL on Wednesday,...
Danaher Corporation announced today that it has completed the previously announced acquisition of AB SCIEX and Molecular Devices. AB SCIEX is a leading designer and manufacturer of mass...
Danaher Corporation announced today that GAAP net earnings for the quarter ended December 31, 2009 were $267 million, or $0.80 per diluted share, a 13% decrease as compared to the Company's 2008...
Danaher Corporation announced today that it has acquired and received acceptances in respect of approximately 97% of the currently issued shares of Genetix Group plc (GTX: AIM) in relation to its...
Danaher Corporation announced today that it will webcast its quarterly earnings conference call for the fourth quarter of 2009 on Thursday, January 28, 2010 beginning at 7:30 a.m. EST and lasting...
Danaher Corporation announced that President and Chief Executive Officer, H. Lawrence Culp, Jr. will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday,...
Danaher Corporation announced today that it will webcast its quarterly earnings conference call for the fourth quarter of 2009 on Thursday, January 28, 2010 beginning at 8:00 a.m. EST and lasting...
Danaher Corporation announced today its intention to make a recommended cash takeover offer, through an indirect wholly owned subsidiary, to acquire all of the issued and to be issued shares of...
At an institutional investor and analyst meeting held in New York today, Danaher Corporation commented on the performance outlook of the company for the balance of 2009 and 2010. President and...
Danaher Corporation announced today that its Board of Directors has appointed Elias A. Zerhouni, M.D. to Danaher's Board of Directors. Dr. Zerhouni's initial term expires at Danaher's 2011 annual...